Development Bank of Wales

The Development Bank of Wales is an independent company that provides commercial funding to small and medium-sized enterprises (SMEs) in Wales. It invests private and public funds, including EU funds, across various sectors such as B2B, healthcare, technology, and life sciences.

David Blake

Investment Executive

Mark Bowman

Venture Fund Manager

Bethan Cousins

New Business Director

Rhian Elston

Investment Director and Member of the Investment Committee

Rhodri Evans

Deputy Fund Manager

Carl Griffiths Ph.D

Technology Seed Fund Manager

Chris Griffiths

Technical Investment Director

Carl Griffiths

Technology Seed Fund Manager

Hannah Mallen

Techonology Venture Investment Graduate

Andrew Morris

Investor

Mike Owen

Group Investment Director

Cenydd Rowlands

Property Director

Sarah Smith

Assistant Investment Executive

Nick Stork

Fund Manager

Giles Thorley

CEO and Board Member

Emily Wood

Investment Executive

Past deals in Industrial Gases

Hexigone Inhibitors

Venture Round in 2024
Hexigone aims to replace toxic chemicals used in the anti-corrosion market with our disruptive, novel, micro/nano reservoir technologies, creating 'smart' coatings. Our additives will enable the coatings to protect for longer in an intelligent manner, increasing the lifetime cycle of the end product, reducing the drain on primary resources.

QLM Technology

Series A in 2022
QLM Technology develops gas detection and imaging systems that use quantum sensing, including ultra-compact, high-precision quantum optical sensors and low-power tunable diode laser Lidar with infrared single-photon detection for natural gas producers, distributors, and service providers. Its technology enables remote detection and quantification of very low leak rates, allowing fast, accurate, and cost-effective identification and monitoring of leaks from well-heads to pipelines, improving safety and reducing operating costs across gas production and distribution assets. The company is based in Bristol, United Kingdom.

QLM Technology

Seed Round in 2021
QLM Technology develops gas detection and imaging systems that use quantum sensing, including ultra-compact, high-precision quantum optical sensors and low-power tunable diode laser Lidar with infrared single-photon detection for natural gas producers, distributors, and service providers. Its technology enables remote detection and quantification of very low leak rates, allowing fast, accurate, and cost-effective identification and monitoring of leaks from well-heads to pipelines, improving safety and reducing operating costs across gas production and distribution assets. The company is based in Bristol, United Kingdom.

Stratium

Seed Round in 2016
Stratium Limited is a manufacturer of mid-infrared quantum cascade lasers (QCL) based in Cardiff, United Kingdom. Established in 2015, the company specializes in providing compound semiconductor lasers to original equipment manufacturers (OEM) for various commercial applications. Stratium's QCLs support critical functions in environmental monitoring, vehicle emission tracking, vehicle collision avoidance, breath diagnostics, and petrochemical process oversight. The lasers are designed to deliver precise mid-infrared emissions essential for advanced gas analysis, utilizing innovative wavelength selection technology that enhances their compactness, stability, and performance. These features make Stratium's products suitable for sensitive detection of molecular species employing techniques such as cavity ring-down spectroscopy, cavity enhanced absorption spectrometry, and photoacoustic spectroscopy, enabling clients to effectively monitor airborne substances.

IMSPEX Diagnostics

Venture Round in 2014
IMSPEX Diagnostics Ltd. develops analytical solutions leveraging ion mobility spectrometry technology for various applications, including clinical diagnostics, environmental analysis, and food safety. Founded in 2011 as a spinoff from the University of Glamorgan, the company produces several instruments, such as FlavourSpec, which analyzes the headspace of liquid samples to assess food freshness and optimize production processes in the food and beverage sectors. Another key product, BreathSpec, examines volatile organic compounds in human breath, aiding in disease detection and monitoring hazardous exposure in workplaces. Additionally, IMSPEX offers GC-IMS, which identifies siloxanes in biogas, assesses air safety in industrial environments, and detects natural gas odors. The company serves a diverse clientele, including blue-chip companies, research hospitals, and universities both in the United Kingdom and internationally. Through its acquisition of GAS GmbH in 2013, IMSPEX enhanced its technological capabilities and market presence, establishing itself as a leader in its field.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.